In vitro activities of amifloxacin and two of its metabolites.

AUTOR(ES)

Venezia, R A

RESUMO

Amifloxacin and two of its metabolites, N-desmethyl amifloxacin and amifloxacin N-oxide, were evaluated by a microdilution MIC susceptibility test against 500 clinical isolates and compared with ciprofloxacin, lomefloxacin, norfloxacin, aztreonam, and imipenem. Of the Staphylococcus species isolates, 208 were methicillin resistant; the MICs for 78 of the isolates of the family Enterobacteriaceae were greater than or equal to 64 micrograms of cefazolin, ampicillin, piperacillin, and mezlocillin per ml. Based on our results, amifloxacin had activity equivalent to those of norfloxacin and lomefloxacin but was less active than ciprofloxacin. The N-oxide metabolite was the least active; however, for the majority of gram-negative bacteria, N-desmethyl amifloxacin was as active as amifloxacin.

Documentos Relacionados

• Hemodialysis clearance of metronidazole and its metabolites.
• In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites.
• Intrahepatic transport and utilization of biliary glutathione and its metabolites.
• Toxicity and mutagenicity of 2,4,-6-trinitrotoluene and its microbial metabolites.
• In vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).